ORBUSNEICH's final dividend is expected to increase by 20% to 12 cents, planning to declare a regular interim dividend

ORBUSNEICH (6929) announced its results, declaring a final dividend of HKD 0.12 per share, a year-on-year increase of 20%. The company is considering the distribution of a regular interim dividend, but no specific ratio has been determined. The U.S. business is recovering rapidly and has entered the Middle Eastern market, with minimal impact from the U.S.-Iran war. The chairman stated that the company's advantage in the U.S. market lies in its global sales network. R&D expenses are expected to rise due to the initiation of clinical research in Japan. Revenue from the mainland has dropped by 13.9% due to the centralized procurement system, but the future impact is expected to be minor